India, Jan. 29 -- OFS Capital Corp. (OFS), a business development company, announced Wednesday the appointment of Kyle Spina as Chief Financial Officer, effective March 31, 2025. Spina will succeed J... Read More
India, Jan. 29 -- Akzo Nobel NV (AKZOY.PK) revealed a profit for fourth quarter that decreased from the same period last year The company's earnings totaled EUR21 million, or EUR0.12 per share. This ... Read More
India, Jan. 29 -- Crypto market sentiment remains subdued as world markets brace for the decision of the Federal Open Market Committee. The Fed in its decision to be announced on Wednesday afternoon i... Read More
India, Jan. 29 -- Bragg Gaming Group Inc. (BRAG), Wednesday announced the preliminary results for the fiscal year 2024, expecting revenue not less than 102 million euros, up 9 percent from last year's... Read More
India, Jan. 29 -- Insurer Progressive Corp. (PGR) reported that December 2024 net income was $942 million or $1.60 per share, up 5 percent from $901 million or $1.53 per share in December 2023. Net p... Read More
India, Jan. 29 -- Italy's non-EU trade surplus declined in December from a year ago, as imports grew faster than exports, preliminary data from the statistical office Istat showed on Wednesday. The n... Read More
India, Jan. 29 -- The major U.S. index futures are currently pointing to a lower open on Wednesday, with stocks likely to move back to the downside following the rebound seen in the previous session. ... Read More
India, Jan. 29 -- Following the rebound seen in the previous session, stocks may move back to the downside in early trading on Wednesday. The major index futures are currently pointing to a lower open... Read More
India, Jan. 29 -- The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET). In the Green Silexion Therapeutics Corp (SLXN) is up over 65% at $2.2... Read More
India, Jan. 29 -- Aethlon Medical Inc. (AEMD), a medical device company, announced on Wednesday, that it has reached a milestone in its Australian safety, feasibility, and dose-finding clinical trial ... Read More